Dechra Pharmaceuticals Posts Higher FY14 Pretax Profit

Dechra Pharmaceuticals PLC

reported a 72% rise in its fiscal 2014 pretax profit and lifted its dividend payment. Dechra Pharma's posted a pretax profit of 21.4 million pounds ($35 million), versus GBP12.5 million, in the year-earlier period. Its revenue rose to GBP193.6 million from GBP189.2 million. Dechra Pharma announced its plans to pay a final dividend of 10.65 pence per share.